Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Jian Li, explained in plain language.
This study tests a new targeted drug (JAB-21822) combined with standard chemotherapy and bevacizumab in 30 Chinese adults with advanced colorectal cancer that has a specific KRAS G12C mutation and has stopped responding to first-line treatment. The goal is to see if the combinati…
Phase: PHASE1 • Sponsor: Jian Li • Aim: Disease control
Last updated May 22, 2026 13:52 UTC